Joshua Thaler is an Endocrinology/Metabolic physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1959 NE Pacific St
C-212, Box 356340
Seattle, WA 981956340
Telephone
206-543-0065Registry record last updated 6 May 2010.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Rhythm Pharmaceuticals, Inc.Program year20251 payment
- Eli Lilly and CompanyProgram year202321 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
63.8%GLP-1 receptor agonist31.6%Ozempic50%Mounjaro29%Trulicity21%Part D<11 patientsSGLT2 inhibitor12.6%Jardiance100%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
20.1%Recombinant Human Growth Hormone10.1%Genotropin66%Omnitrope34%Part D<11 patientsThyroid Hormone Synthesis Inhibitor5.5%Methimazole100%Part D<11 patients+ 1 more class in this area
Nervous system
8.6%Other antiepileptics8.6%Topiramate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- Defining the contributions of hypothalamic microglia and perineuronal nets to obesity pathogenesis
University of Washington
FY2026$888,773R01DK140210 - Metabolic Regulation by Microglial Inflammatory Signaling
University of Washington
FY2026$844,178R01DK119754
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”